nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP3A4—breast cancer	0.15	1	CbGaD
Pentobarbital—CYP2A6—Letrozole—breast cancer	0.148	0.273	CbGbCtD
Pentobarbital—CYP2A6—Tamoxifen—breast cancer	0.0441	0.0814	CbGbCtD
Pentobarbital—CYP2C19—Lapatinib—breast cancer	0.0364	0.0673	CbGbCtD
Pentobarbital—CYP3A4—Exemestane—breast cancer	0.0348	0.0643	CbGbCtD
Pentobarbital—CYP2A6—Fluorouracil—breast cancer	0.0325	0.06	CbGbCtD
Pentobarbital—CYP3A4—Letrozole—breast cancer	0.0296	0.0547	CbGbCtD
Pentobarbital—CYP3A4—Anastrozole—breast cancer	0.0264	0.0487	CbGbCtD
Pentobarbital—CYP3A4—Toremifene—breast cancer	0.0241	0.0446	CbGbCtD
Pentobarbital—CYP3A4—Fulvestrant—breast cancer	0.0225	0.0414	CbGbCtD
Pentobarbital—CYP3A4—Thiotepa—breast cancer	0.02	0.0369	CbGbCtD
Pentobarbital—CYP3A4—Ixabepilone—breast cancer	0.0183	0.0338	CbGbCtD
Pentobarbital—CYP2C19—Tamoxifen—breast cancer	0.0182	0.0337	CbGbCtD
Pentobarbital—CYP3A4—Lapatinib—breast cancer	0.0176	0.0325	CbGbCtD
Pentobarbital—CHRFAM7A—corpus luteum—breast cancer	0.017	0.317	CbGeAlD
Pentobarbital—CHRNA7—corpus luteum—breast cancer	0.0137	0.256	CbGeAlD
Pentobarbital—CYP3A4—Raloxifene—breast cancer	0.0134	0.0246	CbGbCtD
Pentobarbital—CYP3A4—Vinorelbine—breast cancer	0.00977	0.018	CbGbCtD
Pentobarbital—CYP3A4—Tamoxifen—breast cancer	0.00882	0.0163	CbGbCtD
Pentobarbital—CYP3A4—Mitoxantrone—breast cancer	0.0086	0.0159	CbGbCtD
Pentobarbital—CYP3A4—Paclitaxel—breast cancer	0.00687	0.0127	CbGbCtD
Pentobarbital—CYP3A4—Irinotecan—breast cancer	0.00677	0.0125	CbGbCtD
Pentobarbital—CYP3A4—Vinblastine—breast cancer	0.00602	0.0111	CbGbCtD
Pentobarbital—CYP3A4—Docetaxel—breast cancer	0.00496	0.00916	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—breast cancer	0.0037	0.00683	CbGbCtD
Pentobarbital—GRIA2—embryo—breast cancer	0.00197	0.0368	CbGeAlD
Pentobarbital—CHRNA7—skin of body—breast cancer	0.00113	0.021	CbGeAlD
Pentobarbital—GABRA4—pituitary gland—breast cancer	0.00111	0.0207	CbGeAlD
Pentobarbital—CHRFAM7A—female reproductive system—breast cancer	0.00109	0.0203	CbGeAlD
Pentobarbital—GRIA2—endocrine gland—breast cancer	0.00101	0.0189	CbGeAlD
Pentobarbital—CHRFAM7A—female gonad—breast cancer	0.000991	0.0185	CbGeAlD
Pentobarbital—CHRNA7—uterus—breast cancer	0.000978	0.0183	CbGeAlD
Pentobarbital—CYP2A6—adipose tissue—breast cancer	0.000956	0.0179	CbGeAlD
Pentobarbital—GABRG2—pituitary gland—breast cancer	0.000928	0.0173	CbGeAlD
Pentobarbital—CHRFAM7A—endocrine gland—breast cancer	0.000921	0.0172	CbGeAlD
Pentobarbital—GRIK2—endocrine gland—breast cancer	0.000913	0.0171	CbGeAlD
Pentobarbital—GABRA3—endocrine gland—breast cancer	0.000882	0.0165	CbGeAlD
Pentobarbital—CHRNA7—female reproductive system—breast cancer	0.000879	0.0164	CbGeAlD
Pentobarbital—CHRNA7—adrenal gland—breast cancer	0.000858	0.016	CbGeAlD
Pentobarbital—CHRNA4—adrenal gland—breast cancer	0.000847	0.0158	CbGeAlD
Pentobarbital—GABRA2—adipose tissue—breast cancer	0.000845	0.0158	CbGeAlD
Pentobarbital—CHRNA7—female gonad—breast cancer	0.0008	0.015	CbGeAlD
Pentobarbital—GABRA2—adrenal gland—breast cancer	0.000758	0.0142	CbGeAlD
Pentobarbital—CHRNA7—endocrine gland—breast cancer	0.000744	0.0139	CbGeAlD
Pentobarbital—CHRNA4—endocrine gland—breast cancer	0.000734	0.0137	CbGeAlD
Pentobarbital—GABRB3—pituitary gland—breast cancer	0.000713	0.0133	CbGeAlD
Pentobarbital—GABRB3—female reproductive system—breast cancer	0.000653	0.0122	CbGeAlD
Pentobarbital—GABRB3—endocrine gland—breast cancer	0.000552	0.0103	CbGeAlD
Pentobarbital—CYP2C19—endocrine gland—breast cancer	0.000478	0.00894	CbGeAlD
Pentobarbital—GABRA2—lymph node—breast cancer	0.000454	0.00849	CbGeAlD
Pentobarbital—Dermatitis—Anastrozole—breast cancer	0.000407	0.00261	CcSEcCtD
Pentobarbital—Dermatitis—Letrozole—breast cancer	0.000407	0.00261	CcSEcCtD
Pentobarbital—Agitation—Thiotepa—breast cancer	0.000407	0.00261	CcSEcCtD
Pentobarbital—Dizziness—Raloxifene—breast cancer	0.000405	0.0026	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—breast cancer	0.000405	0.0026	CcSEcCtD
Pentobarbital—Headache—Letrozole—breast cancer	0.000405	0.0026	CcSEcCtD
Pentobarbital—Headache—Anastrozole—breast cancer	0.000405	0.0026	CcSEcCtD
Pentobarbital—Hypotension—Melphalan—breast cancer	0.000404	0.0026	CcSEcCtD
Pentobarbital—Ataxia—Capecitabine—breast cancer	0.000399	0.00257	CcSEcCtD
Pentobarbital—Hypotension—Goserelin—breast cancer	0.000395	0.00253	CcSEcCtD
Pentobarbital—Body temperature increased—Chlorambucil—breast cancer	0.000393	0.00252	CcSEcCtD
Pentobarbital—Vomiting—Raloxifene—breast cancer	0.00039	0.0025	CcSEcCtD
Pentobarbital—Vomiting—Idarubicin—breast cancer	0.00039	0.0025	CcSEcCtD
Pentobarbital—Constipation—Vinblastine—breast cancer	0.000389	0.0025	CcSEcCtD
Pentobarbital—Rash—Idarubicin—breast cancer	0.000387	0.00248	CcSEcCtD
Pentobarbital—Rash—Raloxifene—breast cancer	0.000387	0.00248	CcSEcCtD
Pentobarbital—Dermatitis—Idarubicin—breast cancer	0.000386	0.00248	CcSEcCtD
Pentobarbital—Dermatitis—Raloxifene—breast cancer	0.000386	0.00248	CcSEcCtD
Pentobarbital—Headache—Raloxifene—breast cancer	0.000384	0.00247	CcSEcCtD
Pentobarbital—Headache—Idarubicin—breast cancer	0.000384	0.00247	CcSEcCtD
Pentobarbital—Nausea—Anastrozole—breast cancer	0.000384	0.00247	CcSEcCtD
Pentobarbital—Nausea—Letrozole—breast cancer	0.000384	0.00247	CcSEcCtD
Pentobarbital—Constipation—Tamoxifen—breast cancer	0.000378	0.00243	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—breast cancer	0.000377	0.00242	CcSEcCtD
Pentobarbital—Anxiety—Thiotepa—breast cancer	0.000375	0.00241	CcSEcCtD
Pentobarbital—Somnolence—Goserelin—breast cancer	0.000375	0.00241	CcSEcCtD
Pentobarbital—Feeling abnormal—Vinblastine—breast cancer	0.000375	0.00241	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—breast cancer	0.000375	0.00241	CcSEcCtD
Pentobarbital—Hypersensitivity—Chlorambucil—breast cancer	0.000366	0.00235	CcSEcCtD
Pentobarbital—Bradycardia—Paclitaxel—breast cancer	0.000364	0.00234	CcSEcCtD
Pentobarbital—Nausea—Raloxifene—breast cancer	0.000364	0.00234	CcSEcCtD
Pentobarbital—Nausea—Idarubicin—breast cancer	0.000364	0.00234	CcSEcCtD
Pentobarbital—Confusional state—Thiotepa—breast cancer	0.000364	0.00234	CcSEcCtD
Pentobarbital—Constipation—Goserelin—breast cancer	0.000361	0.00232	CcSEcCtD
Pentobarbital—Hypotension—Vinorelbine—breast cancer	0.000353	0.00227	CcSEcCtD
Pentobarbital—Phenobarbital—ABCC1—breast cancer	0.000348	0.324	CrCbGaD
Pentobarbital—Feeling abnormal—Goserelin—breast cancer	0.000348	0.00224	CcSEcCtD
Pentobarbital—Syncope—Irinotecan—breast cancer	0.000343	0.0022	CcSEcCtD
Pentobarbital—Loss of consciousness—Irinotecan—breast cancer	0.000336	0.00216	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinblastine—breast cancer	0.000335	0.00215	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—breast cancer	0.000335	0.00215	CcSEcCtD
Pentobarbital—CYP3A4—female reproductive system—breast cancer	0.000334	0.00624	CbGeAlD
Pentobarbital—Body temperature increased—Goserelin—breast cancer	0.000334	0.00214	CcSEcCtD
Pentobarbital—Hypersensitivity—Tamoxifen—breast cancer	0.000326	0.00209	CcSEcCtD
Pentobarbital—Anxiety—Mitoxantrone—breast cancer	0.000324	0.00208	CcSEcCtD
Pentobarbital—Constipation—Vinorelbine—breast cancer	0.000323	0.00208	CcSEcCtD
Pentobarbital—Somnolence—Thiotepa—breast cancer	0.000321	0.00206	CcSEcCtD
Pentobarbital—Hypersensitivity—Melphalan—breast cancer	0.000319	0.00205	CcSEcCtD
Pentobarbital—Vomiting—Chlorambucil—breast cancer	0.000316	0.00203	CcSEcCtD
Pentobarbital—Confusional state—Irinotecan—breast cancer	0.000314	0.00202	CcSEcCtD
Pentobarbital—Confusional state—Mitoxantrone—breast cancer	0.000314	0.00202	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—breast cancer	0.000314	0.00201	CcSEcCtD
Pentobarbital—Feeling abnormal—Vinorelbine—breast cancer	0.000312	0.002	CcSEcCtD
Pentobarbital—Hypersensitivity—Goserelin—breast cancer	0.000311	0.002	CcSEcCtD
Pentobarbital—Constipation—Thiotepa—breast cancer	0.000309	0.00198	CcSEcCtD
Pentobarbital—Shock—Mitoxantrone—breast cancer	0.000307	0.00197	CcSEcCtD
Pentobarbital—Shock—Irinotecan—breast cancer	0.000307	0.00197	CcSEcCtD
Pentobarbital—Tension—Paclitaxel—breast cancer	0.000306	0.00197	CcSEcCtD
Pentobarbital—Nervousness—Paclitaxel—breast cancer	0.000303	0.00194	CcSEcCtD
Pentobarbital—Confusional state—Fluorouracil—breast cancer	0.000301	0.00194	CcSEcCtD
Pentobarbital—Dizziness—Vinblastine—breast cancer	0.000301	0.00193	CcSEcCtD
Pentobarbital—Bradycardia—Capecitabine—breast cancer	0.000299	0.00192	CcSEcCtD
Pentobarbital—Body temperature increased—Vinorelbine—breast cancer	0.000299	0.00192	CcSEcCtD
Pentobarbital—Feeling abnormal—Thiotepa—breast cancer	0.000298	0.00191	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—breast cancer	0.000297	0.00191	CcSEcCtD
Pentobarbital—Nausea—Chlorambucil—breast cancer	0.000295	0.0019	CcSEcCtD
Pentobarbital—Dizziness—Tamoxifen—breast cancer	0.000292	0.00188	CcSEcCtD
Pentobarbital—Hypotension—Irinotecan—breast cancer	0.000291	0.00187	CcSEcCtD
Pentobarbital—Hypotension—Mitoxantrone—breast cancer	0.000291	0.00187	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—breast cancer	0.00029	0.00186	CcSEcCtD
Pentobarbital—Vomiting—Vinblastine—breast cancer	0.000289	0.00186	CcSEcCtD
Pentobarbital—Agitation—Paclitaxel—breast cancer	0.000286	0.00184	CcSEcCtD
Pentobarbital—Body temperature increased—Thiotepa—breast cancer	0.000286	0.00183	CcSEcCtD
Pentobarbital—Headache—Vinblastine—breast cancer	0.000285	0.00183	CcSEcCtD
Pentobarbital—Angioedema—Paclitaxel—breast cancer	0.000285	0.00183	CcSEcCtD
Pentobarbital—Hypotension—Gemcitabine—breast cancer	0.000284	0.00182	CcSEcCtD
Pentobarbital—CYP3A4—endocrine gland—breast cancer	0.000283	0.00528	CbGeAlD
Pentobarbital—Vomiting—Tamoxifen—breast cancer	0.000281	0.00181	CcSEcCtD
Pentobarbital—Syncope—Paclitaxel—breast cancer	0.000279	0.0018	CcSEcCtD
Pentobarbital—Dizziness—Goserelin—breast cancer	0.000279	0.00179	CcSEcCtD
Pentobarbital—Hypotension—Fluorouracil—breast cancer	0.000279	0.00179	CcSEcCtD
Pentobarbital—Rash—Tamoxifen—breast cancer	0.000279	0.00179	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinorelbine—breast cancer	0.000279	0.00179	CcSEcCtD
Pentobarbital—Dermatitis—Tamoxifen—breast cancer	0.000278	0.00179	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—breast cancer	0.000278	0.00179	CcSEcCtD
Pentobarbital—Somnolence—Mitoxantrone—breast cancer	0.000277	0.00178	CcSEcCtD
Pentobarbital—Somnolence—Irinotecan—breast cancer	0.000277	0.00178	CcSEcCtD
Pentobarbital—Headache—Tamoxifen—breast cancer	0.000277	0.00178	CcSEcCtD
Pentobarbital—Vomiting—Melphalan—breast cancer	0.000275	0.00177	CcSEcCtD
Pentobarbital—Loss of consciousness—Paclitaxel—breast cancer	0.000274	0.00176	CcSEcCtD
Pentobarbital—Rash—Melphalan—breast cancer	0.000273	0.00175	CcSEcCtD
Pentobarbital—Dermatitis—Melphalan—breast cancer	0.000273	0.00175	CcSEcCtD
Pentobarbital—Nausea—Vinblastine—breast cancer	0.00027	0.00174	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—breast cancer	0.00027	0.00174	CcSEcCtD
Pentobarbital—Vomiting—Goserelin—breast cancer	0.000268	0.00172	CcSEcCtD
Pentobarbital—Constipation—Irinotecan—breast cancer	0.000267	0.00171	CcSEcCtD
Pentobarbital—Constipation—Mitoxantrone—breast cancer	0.000267	0.00171	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1B1—breast cancer	0.000266	0.248	CrCbGaD
Pentobarbital—Rash—Goserelin—breast cancer	0.000266	0.00171	CcSEcCtD
Pentobarbital—Hypersensitivity—Thiotepa—breast cancer	0.000266	0.00171	CcSEcCtD
Pentobarbital—Dermatitis—Goserelin—breast cancer	0.000266	0.00171	CcSEcCtD
Pentobarbital—Somnolence—Fluorouracil—breast cancer	0.000266	0.00171	CcSEcCtD
Pentobarbital—Headache—Goserelin—breast cancer	0.000265	0.0017	CcSEcCtD
Pentobarbital—Anxiety—Paclitaxel—breast cancer	0.000264	0.0017	CcSEcCtD
Pentobarbital—Nausea—Tamoxifen—breast cancer	0.000263	0.00169	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—breast cancer	0.00026	0.00167	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—breast cancer	0.000257	0.00165	CcSEcCtD
Pentobarbital—Nausea—Melphalan—breast cancer	0.000257	0.00165	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitoxantrone—breast cancer	0.000257	0.00165	CcSEcCtD
Pentobarbital—Feeling abnormal—Irinotecan—breast cancer	0.000257	0.00165	CcSEcCtD
Pentobarbital—Confusional state—Paclitaxel—breast cancer	0.000256	0.00165	CcSEcCtD
Pentobarbital—Nausea—Goserelin—breast cancer	0.000251	0.00161	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—breast cancer	0.00025	0.00161	CcSEcCtD
Pentobarbital—Shock—Paclitaxel—breast cancer	0.00025	0.00161	CcSEcCtD
Pentobarbital—Dizziness—Vinorelbine—breast cancer	0.00025	0.00161	CcSEcCtD
Pentobarbital—Body temperature increased—Irinotecan—breast cancer	0.000247	0.00158	CcSEcCtD
Pentobarbital—Body temperature increased—Mitoxantrone—breast cancer	0.000247	0.00158	CcSEcCtD
Pentobarbital—Feeling abnormal—Fluorouracil—breast cancer	0.000246	0.00158	CcSEcCtD
Pentobarbital—Vomiting—Vinorelbine—breast cancer	0.00024	0.00154	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—breast cancer	0.00024	0.00154	CcSEcCtD
Pentobarbital—Dizziness—Thiotepa—breast cancer	0.000239	0.00153	CcSEcCtD
Pentobarbital—Rash—Vinorelbine—breast cancer	0.000238	0.00153	CcSEcCtD
Pentobarbital—Dermatitis—Vinorelbine—breast cancer	0.000238	0.00153	CcSEcCtD
Pentobarbital—Hypotension—Paclitaxel—breast cancer	0.000238	0.00153	CcSEcCtD
Pentobarbital—Headache—Vinorelbine—breast cancer	0.000237	0.00152	CcSEcCtD
Pentobarbital—Syncope—Docetaxel—breast cancer	0.000237	0.00152	CcSEcCtD
Pentobarbital—Body temperature increased—Fluorouracil—breast cancer	0.000236	0.00152	CcSEcCtD
Pentobarbital—Loss of consciousness—Docetaxel—breast cancer	0.000232	0.00149	CcSEcCtD
Pentobarbital—Hypersensitivity—Irinotecan—breast cancer	0.00023	0.00148	CcSEcCtD
Pentobarbital—Hypersensitivity—Mitoxantrone—breast cancer	0.00023	0.00148	CcSEcCtD
Pentobarbital—Vomiting—Thiotepa—breast cancer	0.00023	0.00148	CcSEcCtD
Pentobarbital—Syncope—Capecitabine—breast cancer	0.000229	0.00147	CcSEcCtD
Pentobarbital—Rash—Thiotepa—breast cancer	0.000228	0.00146	CcSEcCtD
Pentobarbital—Dermatitis—Thiotepa—breast cancer	0.000228	0.00146	CcSEcCtD
Pentobarbital—Headache—Thiotepa—breast cancer	0.000226	0.00145	CcSEcCtD
Pentobarbital—Somnolence—Paclitaxel—breast cancer	0.000226	0.00145	CcSEcCtD
Pentobarbital—Loss of consciousness—Capecitabine—breast cancer	0.000225	0.00144	CcSEcCtD
Pentobarbital—Nausea—Vinorelbine—breast cancer	0.000225	0.00144	CcSEcCtD
Pentobarbital—Hypersensitivity—Fluorouracil—breast cancer	0.00022	0.00141	CcSEcCtD
Pentobarbital—Constipation—Paclitaxel—breast cancer	0.000218	0.0014	CcSEcCtD
Pentobarbital—Confusional state—Docetaxel—breast cancer	0.000217	0.0014	CcSEcCtD
Pentobarbital—Anxiety—Capecitabine—breast cancer	0.000217	0.00139	CcSEcCtD
Pentobarbital—Nausea—Thiotepa—breast cancer	0.000215	0.00138	CcSEcCtD
Pentobarbital—Shock—Docetaxel—breast cancer	0.000212	0.00136	CcSEcCtD
Pentobarbital—Confusional state—Capecitabine—breast cancer	0.00021	0.00135	CcSEcCtD
Pentobarbital—Feeling abnormal—Paclitaxel—breast cancer	0.00021	0.00135	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—breast cancer	0.000208	0.00134	CcSEcCtD
Pentobarbital—Dizziness—Irinotecan—breast cancer	0.000206	0.00133	CcSEcCtD
Pentobarbital—Shock—Capecitabine—breast cancer	0.000205	0.00132	CcSEcCtD
Pentobarbital—Hypotension—Docetaxel—breast cancer	0.000201	0.00129	CcSEcCtD
Pentobarbital—Body temperature increased—Paclitaxel—breast cancer	0.000201	0.00129	CcSEcCtD
Pentobarbital—Vomiting—Mitoxantrone—breast cancer	0.000198	0.00127	CcSEcCtD
Pentobarbital—Vomiting—Irinotecan—breast cancer	0.000198	0.00127	CcSEcCtD
Pentobarbital—Dizziness—Fluorouracil—breast cancer	0.000198	0.00127	CcSEcCtD
Pentobarbital—Rash—Mitoxantrone—breast cancer	0.000197	0.00126	CcSEcCtD
Pentobarbital—Rash—Irinotecan—breast cancer	0.000197	0.00126	CcSEcCtD
Pentobarbital—Dermatitis—Mitoxantrone—breast cancer	0.000196	0.00126	CcSEcCtD
Pentobarbital—Dermatitis—Irinotecan—breast cancer	0.000196	0.00126	CcSEcCtD
Pentobarbital—Headache—Mitoxantrone—breast cancer	0.000195	0.00126	CcSEcCtD
Pentobarbital—Headache—Irinotecan—breast cancer	0.000195	0.00126	CcSEcCtD
Pentobarbital—Hypotension—Capecitabine—breast cancer	0.000195	0.00125	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—breast cancer	0.000193	0.00124	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—breast cancer	0.000193	0.00124	CcSEcCtD
Pentobarbital—Somnolence—Docetaxel—breast cancer	0.000192	0.00123	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—breast cancer	0.000192	0.00123	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—breast cancer	0.000191	0.00123	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—breast cancer	0.00019	0.00122	CcSEcCtD
Pentobarbital—Vomiting—Fluorouracil—breast cancer	0.00019	0.00122	CcSEcCtD
Pentobarbital—Rash—Fluorouracil—breast cancer	0.000188	0.00121	CcSEcCtD
Pentobarbital—Dermatitis—Fluorouracil—breast cancer	0.000188	0.00121	CcSEcCtD
Pentobarbital—Hypersensitivity—Paclitaxel—breast cancer	0.000187	0.0012	CcSEcCtD
Pentobarbital—Headache—Fluorouracil—breast cancer	0.000187	0.0012	CcSEcCtD
Pentobarbital—Nausea—Mitoxantrone—breast cancer	0.000185	0.00119	CcSEcCtD
Pentobarbital—Nausea—Irinotecan—breast cancer	0.000185	0.00119	CcSEcCtD
Pentobarbital—Constipation—Docetaxel—breast cancer	0.000184	0.00118	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—breast cancer	0.00018	0.00116	CcSEcCtD
Pentobarbital—Constipation—Capecitabine—breast cancer	0.000179	0.00115	CcSEcCtD
Pentobarbital—Feeling abnormal—Docetaxel—breast cancer	0.000178	0.00114	CcSEcCtD
Pentobarbital—Nausea—Fluorouracil—breast cancer	0.000177	0.00114	CcSEcCtD
Pentobarbital—Tension—Epirubicin—breast cancer	0.000175	0.00112	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—breast cancer	0.000173	0.00111	CcSEcCtD
Pentobarbital—Feeling abnormal—Capecitabine—breast cancer	0.000172	0.00111	CcSEcCtD
Pentobarbital—Body temperature increased—Docetaxel—breast cancer	0.00017	0.0011	CcSEcCtD
Pentobarbital—Dizziness—Paclitaxel—breast cancer	0.000168	0.00108	CcSEcCtD
Pentobarbital—Body temperature increased—Capecitabine—breast cancer	0.000165	0.00106	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—breast cancer	0.000164	0.00105	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—breast cancer	0.000162	0.00104	CcSEcCtD
Pentobarbital—Vomiting—Paclitaxel—breast cancer	0.000162	0.00104	CcSEcCtD
Pentobarbital—Rash—Paclitaxel—breast cancer	0.00016	0.00103	CcSEcCtD
Pentobarbital—Dermatitis—Paclitaxel—breast cancer	0.00016	0.00103	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—breast cancer	0.00016	0.00103	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—breast cancer	0.00016	0.00103	CcSEcCtD
Pentobarbital—Headache—Paclitaxel—breast cancer	0.000159	0.00102	CcSEcCtD
Pentobarbital—Hypersensitivity—Docetaxel—breast cancer	0.000159	0.00102	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—breast cancer	0.000157	0.00101	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—breast cancer	0.000157	0.00101	CcSEcCtD
Pentobarbital—Hypersensitivity—Capecitabine—breast cancer	0.000154	0.000988	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—breast cancer	0.000152	0.000973	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—breast cancer	0.000151	0.000971	CcSEcCtD
Pentobarbital—Nausea—Paclitaxel—breast cancer	0.000151	0.000971	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—breast cancer	0.000148	0.00095	CcSEcCtD
Pentobarbital—Thiopental—CYP3A4—breast cancer	0.000148	0.137	CrCbGaD
Pentobarbital—Confusional state—Epirubicin—breast cancer	0.000147	0.000942	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—breast cancer	0.000145	0.000933	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—breast cancer	0.000145	0.000931	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1A1—breast cancer	0.000144	0.134	CrCbGaD
Pentobarbital—Shock—Epirubicin—breast cancer	0.000143	0.000919	CcSEcCtD
Pentobarbital—Dizziness—Docetaxel—breast cancer	0.000143	0.000916	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—breast cancer	0.00014	0.000899	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—breast cancer	0.000138	0.000888	CcSEcCtD
Pentobarbital—Dizziness—Capecitabine—breast cancer	0.000138	0.000887	CcSEcCtD
Pentobarbital—Vomiting—Docetaxel—breast cancer	0.000137	0.000881	CcSEcCtD
Pentobarbital—Rash—Docetaxel—breast cancer	0.000136	0.000873	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—breast cancer	0.000136	0.000873	CcSEcCtD
Pentobarbital—Dermatitis—Docetaxel—breast cancer	0.000136	0.000873	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—breast cancer	0.000136	0.000872	CcSEcCtD
Pentobarbital—Headache—Docetaxel—breast cancer	0.000135	0.000868	CcSEcCtD
Pentobarbital—Vomiting—Capecitabine—breast cancer	0.000133	0.000853	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—breast cancer	0.000132	0.000851	CcSEcCtD
Pentobarbital—Rash—Capecitabine—breast cancer	0.000132	0.000846	CcSEcCtD
Pentobarbital—Dermatitis—Capecitabine—breast cancer	0.000131	0.000845	CcSEcCtD
Pentobarbital—Headache—Capecitabine—breast cancer	0.000131	0.00084	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—breast cancer	0.000129	0.000831	CcSEcCtD
Pentobarbital—Nausea—Docetaxel—breast cancer	0.000128	0.000823	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—breast cancer	0.000128	0.000823	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—breast cancer	0.000126	0.000808	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—breast cancer	0.000124	0.000799	CcSEcCtD
Pentobarbital—Nausea—Capecitabine—breast cancer	0.000124	0.000797	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—breast cancer	0.000123	0.000789	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—breast cancer	0.00012	0.00077	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—breast cancer	0.00012	0.000769	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—breast cancer	0.000115	0.000739	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—breast cancer	0.000115	0.000739	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—breast cancer	0.000114	0.000736	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—breast cancer	0.000111	0.000712	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—breast cancer	0.000107	0.000688	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—breast cancer	0.000106	0.000683	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—breast cancer	0.000103	0.00066	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—breast cancer	9.91e-05	0.000637	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—breast cancer	9.88e-05	0.000635	CcSEcCtD
Pentobarbital—Rash—Methotrexate—breast cancer	9.8e-05	0.00063	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—breast cancer	9.79e-05	0.000629	CcSEcCtD
Pentobarbital—Headache—Methotrexate—breast cancer	9.73e-05	0.000625	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—breast cancer	9.62e-05	0.000618	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—breast cancer	9.25e-05	0.000594	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—breast cancer	9.23e-05	0.000593	CcSEcCtD
Pentobarbital—Phenobarbital—CYP3A4—breast cancer	9.18e-05	0.0855	CrCbGaD
Pentobarbital—Rash—Epirubicin—breast cancer	9.17e-05	0.000589	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—breast cancer	9.16e-05	0.000589	CcSEcCtD
Pentobarbital—Headache—Epirubicin—breast cancer	9.11e-05	0.000585	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—breast cancer	8.9e-05	0.000572	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—breast cancer	8.64e-05	0.000555	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—breast cancer	8.56e-05	0.00055	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—breast cancer	8.48e-05	0.000545	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—breast cancer	8.48e-05	0.000545	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—breast cancer	8.43e-05	0.000542	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—breast cancer	7.99e-05	0.000514	CcSEcCtD
Pentobarbital—Phenobarbital—ABCB1—breast cancer	7.64e-05	0.0711	CrCbGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—breast cancer	1.51e-05	0.000154	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	1.5e-05	0.000153	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—HRAS—breast cancer	1.5e-05	0.000152	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.49e-05	0.000151	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.48e-05	0.00015	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	1.48e-05	0.00015	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—breast cancer	1.46e-05	0.000148	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—HRAS—breast cancer	1.45e-05	0.000148	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—HRAS—breast cancer	1.43e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ANGPTL4—breast cancer	1.42e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ESRRA—breast cancer	1.42e-05	0.000145	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—breast cancer	1.42e-05	0.000144	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—DPYD—breast cancer	1.4e-05	0.000143	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MED12—breast cancer	1.4e-05	0.000143	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—HRAS—breast cancer	1.4e-05	0.000143	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—breast cancer	1.39e-05	0.000142	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—HRAS—breast cancer	1.39e-05	0.000142	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALDOA—breast cancer	1.38e-05	0.00014	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—breast cancer	1.37e-05	0.000139	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HRAS—breast cancer	1.37e-05	0.000139	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	1.36e-05	0.000138	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.35e-05	0.000138	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HADHB—breast cancer	1.35e-05	0.000137	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPI—breast cancer	1.35e-05	0.000137	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA3—breast cancer	1.34e-05	0.000136	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.34e-05	0.000136	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A2—breast cancer	1.33e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CPT1A—breast cancer	1.31e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTR—breast cancer	1.31e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG2—breast cancer	1.31e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SYNJ2—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDH7A1—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDH1A1—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HPGDS—breast cancer	1.28e-05	0.00013	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.27e-05	0.000129	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HBA1—breast cancer	1.27e-05	0.000129	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACHE—breast cancer	1.24e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—breast cancer	1.24e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FHL2—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NME1—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UMPS—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PHGDH—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADSL—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BRIP1—breast cancer	1.21e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPSE—breast cancer	1.21e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LDHB—breast cancer	1.21e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NDUFS3—breast cancer	1.2e-05	0.000122	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HRAS—breast cancer	1.2e-05	0.000122	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP17A1—breast cancer	1.18e-05	0.000119	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	1.17e-05	0.000119	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO1—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS1—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMMR—breast cancer	1.15e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA3—breast cancer	1.15e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCC1—breast cancer	1.15e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2D6—breast cancer	1.14e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CHST9—breast cancer	1.13e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA2—breast cancer	1.12e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARGC1B—breast cancer	1.11e-05	0.000113	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FASN—breast cancer	1.09e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.08e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.08e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—BCHE—breast cancer	1.08e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COX11—breast cancer	1.07e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A5—breast cancer	1.07e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA4—breast cancer	1.05e-05	0.000107	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA9—breast cancer	1.05e-05	0.000107	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.04e-05	0.000105	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—breast cancer	1.03e-05	0.000105	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A1—breast cancer	1.03e-05	0.000105	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.03e-05	0.000104	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX2—breast cancer	1.02e-05	0.000104	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA2—breast cancer	1.02e-05	0.000104	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SULT1A1—breast cancer	1.01e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX4—breast cancer	1.01e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP3A4—breast cancer	1.01e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1B1—breast cancer	9.89e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—IDH1—breast cancer	9.87e-06	0.0001	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA1—breast cancer	9.87e-06	0.0001	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CDA—breast cancer	9.8e-06	9.96e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SHMT1—breast cancer	9.8e-06	9.96e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAT2—breast cancer	9.76e-06	9.92e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HSP90AA1—breast cancer	9.7e-06	9.86e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA1—breast cancer	9.44e-06	9.59e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A5—breast cancer	9.43e-06	9.59e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.43e-06	9.59e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—STK11—breast cancer	9.3e-06	9.45e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP19A1—breast cancer	9.3e-06	9.45e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APRT—breast cancer	9.11e-06	9.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.83e-06	8.97e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—COMT—breast cancer	8.65e-06	8.79e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—breast cancer	8.61e-06	8.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ESRRA—breast cancer	8.57e-06	8.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.57e-06	8.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MED12—breast cancer	8.56e-06	8.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—DPYD—breast cancer	8.56e-06	8.7e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMOX1—breast cancer	8.49e-06	8.63e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ITPR1—breast cancer	8.47e-06	8.61e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDOA—breast cancer	8.43e-06	8.56e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA3—breast cancer	8.18e-06	8.31e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—breast cancer	8.15e-06	8.28e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A2—breast cancer	8.12e-06	8.26e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPI—breast cancer	8.12e-06	8.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HADHB—breast cancer	8.12e-06	8.25e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.04e-06	8.17e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMS—breast cancer	8e-06	8.13e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CPT1A—breast cancer	7.96e-06	8.09e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTR—breast cancer	7.96e-06	8.09e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG2—breast cancer	7.96e-06	8.09e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—breast cancer	7.91e-06	8.04e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOR1—breast cancer	7.91e-06	8.04e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLA2G4A—breast cancer	7.91e-06	8.04e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPGDS—breast cancer	7.8e-06	7.93e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HBA1—breast cancer	7.76e-06	7.88e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.75e-06	7.87e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.75e-06	7.87e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—breast cancer	7.57e-06	7.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACHE—breast cancer	7.57e-06	7.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—breast cancer	7.57e-06	7.69e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A1—breast cancer	7.5e-06	7.62e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ERCC2—breast cancer	7.44e-06	7.56e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADSL—breast cancer	7.43e-06	7.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UMPS—breast cancer	7.43e-06	7.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PHGDH—breast cancer	7.43e-06	7.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FHL2—breast cancer	7.43e-06	7.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NME1—breast cancer	7.43e-06	7.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPSE—breast cancer	7.28e-06	7.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BRIP1—breast cancer	7.28e-06	7.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LDHB—breast cancer	7.28e-06	7.4e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP17A1—breast cancer	7.17e-06	7.28e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS1—breast cancer	7.09e-06	7.21e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO1—breast cancer	7.09e-06	7.21e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.07e-06	7.18e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—breast cancer	6.99e-06	7.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.98e-06	7.09e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2D6—breast cancer	6.96e-06	7.07e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMMR—breast cancer	6.9e-06	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA3—breast cancer	6.9e-06	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCC1—breast cancer	6.9e-06	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA2—breast cancer	6.83e-06	6.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.69e-06	6.8e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FASN—breast cancer	6.62e-06	6.73e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BCHE—breast cancer	6.59e-06	6.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A5—breast cancer	6.51e-06	6.62e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAV1—breast cancer	6.45e-06	6.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA4—breast cancer	6.31e-06	6.42e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA9—breast cancer	6.31e-06	6.42e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A1—breast cancer	6.29e-06	6.39e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—breast cancer	6.29e-06	6.39e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.16e-06	6.26e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA2—breast cancer	6.15e-06	6.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX2—breast cancer	6.15e-06	6.25e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP3A4—breast cancer	6.13e-06	6.23e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.1e-06	6.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX4—breast cancer	6.08e-06	6.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SULT1A1—breast cancer	6.08e-06	6.18e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1B1—breast cancer	6.03e-06	6.13e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA1—breast cancer	5.94e-06	6.03e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—IDH1—breast cancer	5.94e-06	6.03e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSP90AA1—breast cancer	5.91e-06	6.01e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—breast cancer	5.87e-06	5.97e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAT2—breast cancer	5.87e-06	5.97e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA1—breast cancer	5.75e-06	5.85e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—STK11—breast cancer	5.67e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP19A1—breast cancer	5.67e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.32e-06	5.41e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—COMT—breast cancer	5.27e-06	5.36e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—breast cancer	5.25e-06	5.33e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMOX1—breast cancer	5.17e-06	5.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ITPR1—breast cancer	5.16e-06	5.25e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CD—breast cancer	5.16e-06	5.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MED12—breast cancer	5.15e-06	5.23e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—DPYD—breast cancer	5.15e-06	5.23e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—breast cancer	5.1e-06	5.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDOA—breast cancer	5.07e-06	5.15e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—breast cancer	4.97e-06	5.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA3—breast cancer	4.92e-06	5e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A2—breast cancer	4.88e-06	4.96e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMS—breast cancer	4.88e-06	4.96e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—breast cancer	4.87e-06	4.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLA2G4A—breast cancer	4.82e-06	4.9e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOR1—breast cancer	4.82e-06	4.9e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—breast cancer	4.82e-06	4.9e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CPT1A—breast cancer	4.79e-06	4.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTR—breast cancer	4.79e-06	4.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG2—breast cancer	4.79e-06	4.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPGDS—breast cancer	4.69e-06	4.77e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HBA1—breast cancer	4.66e-06	4.74e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—breast cancer	4.62e-06	4.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A1—breast cancer	4.57e-06	4.65e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—breast cancer	4.55e-06	4.63e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACHE—breast cancer	4.55e-06	4.63e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ERCC2—breast cancer	4.53e-06	4.61e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CB—breast cancer	4.5e-06	4.57e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—breast cancer	4.46e-06	4.53e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP17A1—breast cancer	4.31e-06	4.38e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO1—breast cancer	4.27e-06	4.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS1—breast cancer	4.27e-06	4.34e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—breast cancer	4.26e-06	4.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2D6—breast cancer	4.18e-06	4.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA2—breast cancer	4.11e-06	4.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FASN—breast cancer	3.98e-06	4.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BCHE—breast cancer	3.97e-06	4.03e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAV1—breast cancer	3.93e-06	3.99e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A5—breast cancer	3.92e-06	3.98e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—breast cancer	3.89e-06	3.95e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—breast cancer	3.78e-06	3.84e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A1—breast cancer	3.78e-06	3.84e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.76e-06	3.82e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1B1—breast cancer	3.63e-06	3.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—breast cancer	3.58e-06	3.64e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.56e-06	3.61e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA1—breast cancer	3.46e-06	3.52e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—STK11—breast cancer	3.41e-06	3.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP19A1—breast cancer	3.41e-06	3.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COMT—breast cancer	3.17e-06	3.22e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—breast cancer	3.16e-06	3.21e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CD—breast cancer	3.15e-06	3.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMOX1—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ITPR1—breast cancer	3.1e-06	3.16e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—breast cancer	2.99e-06	3.04e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—breast cancer	2.97e-06	3.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMS—breast cancer	2.93e-06	2.98e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.9e-06	2.95e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—breast cancer	2.9e-06	2.95e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOR1—breast cancer	2.9e-06	2.95e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—breast cancer	2.78e-06	2.82e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A1—breast cancer	2.75e-06	2.79e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CB—breast cancer	2.74e-06	2.79e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—breast cancer	2.74e-06	2.79e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ERCC2—breast cancer	2.73e-06	2.77e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—breast cancer	2.72e-06	2.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—breast cancer	2.56e-06	2.6e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—breast cancer	2.37e-06	2.41e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAV1—breast cancer	2.36e-06	2.4e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—breast cancer	2.24e-06	2.28e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—breast cancer	2.15e-06	2.19e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CD—breast cancer	1.89e-06	1.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—breast cancer	1.87e-06	1.9e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—breast cancer	1.79e-06	1.82e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—breast cancer	1.67e-06	1.7e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CB—breast cancer	1.65e-06	1.68e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—breast cancer	1.63e-06	1.66e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—breast cancer	1.43e-06	1.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—breast cancer	1.37e-06	1.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—breast cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—breast cancer	8.22e-07	8.35e-06	CbGpPWpGaD
